UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Cut by Lindbrook Capital LLC

Lindbrook Capital LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,849 shares of the healthcare conglomerate’s stock after selling 264 shares during the quarter. UnitedHealth Group accounts for 0.6% of Lindbrook Capital LLC’s portfolio, making the stock its 27th largest holding. Lindbrook Capital LLC’s holdings in UnitedHealth Group were worth $6,500,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $30,000. Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $32,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $37,000. Finally, DecisionPoint Financial LLC lifted its holdings in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 0.3 %

Shares of NYSE:UNH opened at $476.22 on Thursday. The company has a market cap of $438.25 billion, a P/E ratio of 30.72, a P/E/G ratio of 1.37 and a beta of 0.61. The stock’s 50-day moving average is $514.58 and its 200-day moving average is $554.81. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the business earned $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.